Publications, Pharmaceutical

Developing a Dry Powder Formulation for Aptar Pharma Prohaler®

Aptar Pharma Prohaler® is a novel, high performance, multidose dry powder inhaler device with a patient-centric design developed to promote patient compliance.

This paper describes the optimization of a model formulation for Prohaler® via manipulation of the concentration of fine lactose and the inclusion of a force control agent, to reduce the strength of interparticle forces and promote dose deaggregation. The relationship between formulation composition and dissolution profile was also investigated. The inclusion of a force control agent was shown to be highly beneficial in promoting aerosolization, resulting in a higher fine particle mass and a finer mass median aerodynamic diameter. This effect was robust with respect to lactose fine concentration which in the absence of a force control agent was also observed to correlate positively with fine particle mass. Consideration of the use of force control agents is highly recommended when developing formulations for Prohaler®.

Download Publication
8 May 2021

Learn more about Prohaler®

Find Out More

This Might Also Be of Interest

2 Jun 2021

Aptar Pharma discusses how digital solutions improve patient outcomes

Webinars, Pharmaceutical, Innovation & Insights, Drug Delivery Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
15 May 2021

Demonstrating bioequivalence for generic fluticasone propionate OINDPs

Publications, Pharmaceutical, Innovation & Insights, Drug Delivery Innovations, Product Solutions

Read More
15 May 2021

Evaluation of Albuterol Sulfate with Low Global Warming Potential Propellants

Publications, Pharmaceutical, Sustainability, Drug Delivery Innovations, Brand Differentiation, Product Solutions

Read More
8 May 2021

Investigating Storage Options for Pressurized Metered Dose Inhalers

Publications, Pharmaceutical, Innovation & Insights, Drug Delivery Innovations, Product Solutions

Read More
1 11 12 13 14 15 20

Request Access

Close

Requesting access to Developing a Dry Powder Formulation for Aptar Pharma Prohaler®.

  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is for validation purposes and should be left unchanged.
Back To Top